Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM movers: Trackwise Designs, Southern Energy, Premier African Minerals, Tasty

Naked Wine slumps on disappointing figures

AIM movers: Tandem, Engage XR, iEnergizer, Bango, Phoenix Global Resources, ex-dividends

Proposed acquistion for Roquefort Therapeutics

AIM movers: Jade Road Investments, Bonhill, System1, Phoenix Global Resources, NetScientific

DSM deal provides profit boost for Provexis

NetScientific raises cash for further investments

AIM movers: Morses Club, K3 Capital, James Cropper, Midatech Pharma

Directors dealings: Continuing share purchases at Alphawave IP

Euromoney one-quarter higher on bid approach

Ocado seeks £575m for investment

AIM movers, Filtronic, Actual Experience, Forward Partners, Jadestone Energy, Alien Metals, Plexus

AIM weekly movers: Xeros Technology set to clean up

Aquis weekly movers: Psych Capital back above placing price

AIM movers: Providence Resources, Directa Plus

M&C Saatchi board withdraws bid recommendation

AIM movers: Rockhopper Exploration, Zambeef, Wynnstay Properties, GB Group

Best of the Best cash return

JLEN Environmental increases NAV by 25%

Record order book for Severfield

DP Poland acquires new boss

AIM movers: Dillistone, Redx Pharma, Saietta, AssetCo, SpaceandPeople

Altus Strategies agrees merger with Canadian rival

Driver stems Middle East losses

Vianet set to return to profit

AIM movers: Revolution Bars, Verici Dx, Condor Gold, Tekmar, Devlover Digital

Xeros Technology share price doubles on licence deal

Go-Ahead recommends consortium bid

Palm oil price rise partly offsets lower production at Dekel Agri-Vision

Tekmar seeks partner, Scirocco and Wentworth deal, N4 Pharma Nuvec progress

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020